Obesity and loss of disease-free years owing to major non-communicable diseases: a multicohort study

The Lancet Public Health

Volumn 3, Issue 10, 2018, Pages e490-e497

  Nyberg, Solja T ^a   Batty, G David ^b   Pentti, Jaana ^a,c   Virtanen, Marianna ^d,e,f   Alfredsson, Lars ^g,h   Fransson, Eleonor I ^f,i   Goldberg, Marcel ^j,k   Heikkilä, Katriina ^l,m   Jokela, Markus ^a   Knutsson, Anders ⁿ   Koskenvuo, Markku ^a   Lallukka, Tea ^a,d   Leineweber, Constanze ^f   Lindbohm, Joni V ^a   Madsen, Ida E H ^o   Magnusson Hanson, Linda L ^f   Nordin, Maria ^f,p   Oksanen, Tuula ^d   Pietiläinen, Olli ^a   Rahkonen, Ossi ^a   Rugulies, Reiner ^o,q   Shipley, Martin J ^b   Stenholm, Sari ^c,r   Suominen, Sakari ^c,s   Theorell, Töres ^f   Vahtera, Jussi ^c   Westerholm, Peter J M ^e   Westerlund, Hugo ^f   Zins, Marie ^j,k   Hamer, Mark ^t   Singh Manoux, Archana ^b,u   Bell, Joshua A ^v   Ferrie, Jane E ^b,w   Kivimäki, Mika ^a,b   more..

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF TURKU   (Finland)

^d FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^e UPPSALA UNIVERSITY   (Sweden)

^f STOCKHOLM UNIVERSITY   (Sweden)

^g STOCKHOLM COUNTY COUNCIL   (Sweden)

^h KAROLINSKA INSTITUTE   (Sweden)

ⁱ JÖNKÖPING UNIVERSITY   (Sweden)

^j UNIVERSITÉ PARIS DESCARTES   (France)

^k UMS 011   (France)

^l LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^m ROYAL COLLEGE OF SURGEONS OF ENGLAND   (United Kingdom)

ⁿ MID SWEDEN UNIVERSITY   (Sweden)

^o NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^p UMEÅ UNIVERSITY   (Sweden)

^q UNIVERSITY OF COPENHAGEN   (Denmark)

^r TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^s UNIVERSITY OF SKÖVDE   (Sweden)

^t LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^u CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^v UNIVERSITY OF BRISTOL   (United Kingdom)

^w UNIVERSITY OF BRISTOL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE; MALE; MORTALITY; NON COMMUNICABLE DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; PHYSICAL INACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SMOKING; SOCIOECONOMICS; UNDERWEIGHT; COMPLICATION; EUROPE; MIDDLE AGED;

ADULT; AGED; BODY MASS INDEX; COHORT STUDIES; EUROPE; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; NONCOMMUNICABLE DISEASES; OBESITY; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 85054896279     PISSN: None     EISSN: 24682667     Source Type: Journal    
DOI: 10.1016/S2468-2667(18)30139-7     Document Type: Article

References (43)

1. Ng, M, Fleming, T, Robinson, M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384 (2014), 766–781.
2. Kent, S, Green, J, Reeves, G, et al., for the Million Women Study collaborators. Hospital costs in relation to body-mass index in 1·1 million women in England: a prospective cohort study. Lancet Public Health 2 (2017), e214–e222.
3. WHO. Obesity and overweight. Key facts. http://www.who.int/mediacentre/factsheets/fs311/en/. (Accessed 18 January 2018)
4. Taylor, VH, Forhan, M, Vigod, SN, McIntyre, RS, Morrison, KM, The impact of obesity on quality of life. Best Pract Res Clin Endocrinol Metab 27 (2013), 139–146.
5. Grover, SA, Kaouache, M, Rempel, P, et al. Years of life lost and healthy life-years lost from diabetes and cardiovascular disease in overweight and obese people: a modelling study. Lancet Diabetes Endocrinol 3 (2015), 114–122.
6. Poirier, P, Giles, TD, Bray, GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association scientific statement on obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113 (2006), 898–918.
7. Guh, DP, Zhang, W, Bansback, N, Amarsi, Z, Birmingham, CL, Anis, AH, The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health, 9, 2009, 88.
8. Lauby-Secretan, B, Scoccianti, C, Loomis, D, et al. Body fatness and cancer—viewpoint of the IARC Working Group. N Engl J Med 375 (2016), 794–798.
9. Lavie, CJ, De Schutter, A, Milani, RV, Healthy obese versus unhealthy lean: the obesity paradox. Nat Rev Endocrinol 11 (2015), 55–62.
10. Lassale, C, Tzoulaki, I, Moons, KGM, et al. Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis. Eur Heart J 39 (2018), 397–406.
11. Bell, JA, Hamer, M, Batty, GD, Singh-Manoux, A, Sabia, S, Kivimaki, M, Incidence of metabolic risk factors among healthy obese adults: 20-year follow-up. J Am Coll Cardiol 66 (2015), 871–873.
12. Nusselder, WJ, Franco, OH, Peeters, A, Mackenbach, JP, Living healthier for longer: comparative effects of three heart-healthy behaviors on life expectancy with and without cardiovascular disease. BMC Public Health, 9, 2009, 487.
13. Stenholm, S, Head, J, Aalto, V, et al. Body mass index as a predictor of healthy and disease-free life expectancy between ages 50 and 75: a multicohort study. Int J Obes (Lond) 41 (2017), 769–775.
14. O'Doherty, MG, Cairns, K, O'Neill, V, et al. Effect of major lifestyle risk factors, independent and jointly, on life expectancy with and without cardiovascular disease: results from the Consortium on Health and Ageing Network of Cohorts in Europe and the United States (CHANCES). Eur J Epidemiol 31 (2016), 455–468.
15. Pardo Silva, MC, De Laet, C, Nusselder, WJ, Mamun, AA, Peeters, A, Adult obesity and number of years lived with and without cardiovascular disease. Obesity (Silver Spring) 14 (2006), 1264–1273.
16. Holtermann, A, Gyntelberg, F, Bauman, A, Thorsten Jensen, M, Cardiorespiratory fitness, fatness and incident diabetes. Diabetes Res Clin Pract 134 (2017), 113–120.
17. Ortega, FB, Lavie, CJ, Blair, SN, Obesity and cardiovascular disease. Circulation Res 118 (2016), 1752–1770.
18. Kennedy, AB, Lavie, CJ, Blair, SN, Fitness or fatness: which is more important?. JAMA 319 (2018), 231–232.
19. Kivimaki, M, Nyberg, ST, Batty, GD, et al. Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data. Lancet 380 (2012), 1491–1497.
20. GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390 (2017), 1151–1210.
21. Tunstall-Pedoe, H, Kuulasmaa, K, Amouyel, P, Arveiler, D, Rajakangas, AM, Pajak, A, Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90 (1994), 583–612.
22. Nyberg, ST, Fransson, EI, Heikkila, K, et al. Job strain as a risk factor for type 2 diabetes: a pooled analysis of 124,808 men and women. Diabetes Care 37 (2014), 2268–2275.
23. Royston, P, Parmar, MK, Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med 21 (2002), 2175–2197.
24. Goff, DC Jr, Lloyd-Jones, DM, Bennett, G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63 (2014), 2935–2959.
25. Piepoli, MF, Hoes, AW, Agewall, S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 37 (2016), 2315–2381.
26. Hellquist, BN, Duffy, SW, Abdsaleh, S, et al. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer 117 (2011), 714–722.
27. Lambert, PC, Royston, P, Further development of flexible parametric models for survival analysis. Stata J 9 (2009), 265–290.
28. Harris, R, Bradburn, M, Deeks, J, Harbord, R, Altman, D, Sterne, J, metan: fixed- and random-effects meta-analysis. Stata J 8 (2008), 3–28.
29. Dale, CE, Fatemifar, G, Palmer, TM, et al. Causal associations of adiposity and body fat distribution with coronary heart disease, stroke subtypes, and type 2 diabetes mellitus: a mendelian randomization analysis. Circulation 135 (2017), 2373–2388.
30. Global BMI Mortality Collaboration, Di Angelantonio, E, Bhupathiraju, ShN, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet 388 (2016), 776–786.
31. Kahn, SE, Hull, RL, Utzschneider, KM, Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444 (2006), 840–846.
32. Heymsfield, SB, Wadden, TA, Mechanisms, pathophysiology, and management of obesity. N Engl J Med 376 (2017), 254–266.
33. Carreras-Torres, R, Johansson, M, Gaborieau, V, et al. The role of obesity, type 2 diabetes, and metabolic factors in pancreatic cancer: a mendelian randomization study. J Natl Cancer Inst, 2017 published online Sept 1. DOI:10.1093/jnci/djx012.
34. Nead, KT, Sharp, SJ, Thompson, DJ, et al. Evidence of a causal association between insulinemia and endometrial cancer: a mendelian randomization analysis. J Natl Cancer Inst, 107, 2015, djv178.
35. Calle, EE, Kaaks, R, Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4 (2004), 579–591.
36. Mathis, D, Shoelson, SE, Immunometabolism: an emerging frontier. Nat Rev Immunol, 11, 2011, 81.
37. Flegal, KM, Graubard, BI, Williamson, DF, Gail, MH, Excess deaths associated with underweight, overweight, and obesity. JAMA 293 (2005), 1861–1867.
38. Romagnani, P, Remuzzi, G, Glassock, R, et al. Chronic kidney disease. Nat Rev Dis Primers, 3, 2017, 17088.
39. Villarejo, C, Fernandez-Aranda, F, Jimenez-Murcia, S, et al. Lifetime obesity in patients with eating disorders: increasing prevalence, clinical and personality correlates. Eur Eat Disord Rev 20 (2012), 250–254.
40. Wluka, AE, Lombard, CB, Cicuttini, FM, Tackling obesity in knee osteoarthritis. Nat Rev Rheumatol 9 (2013), 225–235.
41. Jordan, AS, McSharry, DG, Malhotra, A, Adult obstructive sleep apnoea. Lancet 383 (2014), 736–747.
42. Thompson, AE, Anisimowicz, Y, Miedema, B, Hogg, W, Wodchis, WP, Aubrey-Bassler, K, The influence of gender and other patient characteristics on health care-seeking behaviour: a QUALICOPC study. BMC Fam Pract, 17, 2016, 38.
43. Neeland, IJ, Poirier, P, Despres, JP, Cardiovascular and metabolic heterogeneity of obesity: clinical challenges and implications for management. Circulation 137 (2018), 1391–1406.